Jiangsu Hengrui Medicine Co. Ltd Financials

Market Capitalization CN¥346.69 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	47.98
Forward PE	51.27
Price to Sales TTM	CN¥11.88
Price to Book MRQ	CN¥6.95
Enterprise to Revenue	10.30
Enterprise to EBITDA	38.77

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	23.44%
Operating Margin	28.11%
Return on Assets TTM	8.99%
Return on Equity TTM	15.22%

Income Statement

Revenue TTM	CN¥29,192,683,520
Revenue per Share TTM	CN¥4.66
Quarterly Revenue Growth	20.10%
Gross Profit TTM	CN¥25,186,154,496
EBITDA	CN¥7,662,644,102
Net Income to Common TTM	CN¥6,841,653,248
Diluted EPS TTM	CN¥1.09
Quarterly Earnings Growth YoY	36.90%

Balance Sheet

Total Cash MRQ	CN¥24,195,823,616
Total Cash per Share MRQ	CN¥3.87
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	0.23
Current Ratio MRQ	10.70
Book Value per Share MRQ	CN¥7.52

Cash Flow

Operating Cash Flow TTM	CN¥6,723,328,000
Levered Free Cash Flow TTM	CN¥3,133,839,616

600276 Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	6,379,002,274
Float Shares	3,470,813,295
Avg 10 Volume	35,329,890
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	47.31%
% Held by Institutions	15.79%

Stock Price Summary

Beta	0.39
Fifty Two Week Low	CN¥38.01
Fifty Two Week High	CN¥57.53
Fifty Two Week Change	26.38%
Day 50 MA	CN¥52.79
Day 200 MA	CN¥48.72

Dividends and Splits

Forward Annual Dividend Rate	CN¥0.80
Forward Annual Dividend Yield	1.50%
Trailing Annual Dividend Rate	CN¥0.20
Trailing Annual Dividend Yield	0.38%
Payout Ratio	18.35%
Dividend Date
Ex Dividend Date	2025-05-23
Last Split Factor
Last Split Date	2021-06-10